
Please try another search
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Koichi Shimada | 67 | 2018 | Director |
Toshie Takeuchi | 70 | 2020 | Independent Outside Director |
Takashi Ito | 65 | 2018 | Independent Outside Director |
Manabu Kinoshita | 71 | 2020 | Independent Outside Director |
Kimiko Kunimasa | 65 | 2022 | Independent Outside Director |
Sachiko Iizuka | 56 | 2025 | Independent Outside Director |
Yuji Ueda | 64 | 2022 | Director |
Hiroshi Kizaki | 66 | 2023 | Independent Outside Director |
Ryuji Arakawa | 62 | 2016 | President & Representative Director |
Yusuke Fukujin | 49 | 2020 | Executive VP & Representative Director |
Toshiki Tanaka | 62 | 2022 | Managing Executive Officer of Corporate Affairs & Director |
Shigeki Ohashi | 60 | 2022 | Managing Executive Officer of Business Strategy & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review